End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.71 CNY | -0.11% | -10.37% | -35.23% |
May. 28 | Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK | MT |
May. 28 | China Gives Nod to Bio-Thera Solutions' Clinical Trials for Anti-Tumor Drug Combo | MT |
Sales 2024 * | 1.49B 206M | Sales 2025 * | 2.48B 343M | Capitalization | 11.06B 1.53B |
---|---|---|---|---|---|
Net income 2024 * | -22M -3.04M | Net income 2025 * | 571M 78.82M | EV / Sales 2024 * | 7.42 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.45 x |
P/E ratio 2024 * |
-534
x | P/E ratio 2025 * |
19.4
x | Employees | 1,167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 20.8% |
1 day | -0.11% | ||
1 week | -10.37% | ||
Current month | -19.35% | ||
1 month | -16.66% | ||
3 months | -30.33% | ||
6 months | -35.33% | ||
Current year | -35.23% |
Managers | Title | Age | Since |
---|---|---|---|
Sheng Feng Li
CEO | Chief Executive Officer | 65 | 03-07-27 |
Xian Hong Zhan
DFI | Director of Finance/CFO | 46 | 19-04-18 |
Xiao Yun Wu
CHM | Chairman | 43 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
De Han Huang
BRD | Director/Board Member | 59 | 22-05-19 |
Sheng Feng Li
CEO | Chief Executive Officer | 65 | 03-07-27 |
Jin Chen Yu
BRD | Director/Board Member | 66 | 12-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 26.71 | -0.11% | 1,225,513 |
24-05-27 | 26.74 | -0.63% | 2,102,162 |
24-05-24 | 26.91 | -1.75% | 2,263,497 |
24-05-23 | 27.39 | -4.90% | 1,907,410 |
24-05-22 | 28.8 | -1.13% | 1,100,400 |
End-of-day quote Shanghai S.E., May 27, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.23% | 1.53B | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- 688177 Stock